Suppr超能文献

相似文献

1
CTIVA: Censored time interval variable analysis.
PLoS One. 2023 Nov 16;18(11):e0294513. doi: 10.1371/journal.pone.0294513. eCollection 2023.
2
Regression models for interval censored data using parametric pseudo-observations.
BMC Med Res Methodol. 2021 Feb 15;21(1):36. doi: 10.1186/s12874-021-01227-8.
3
Network estimation for censored time-to-event data for multiple events based on multivariate survival analysis.
PLoS One. 2020 Oct 1;15(10):e0239760. doi: 10.1371/journal.pone.0239760. eCollection 2020.
4
Variable selection in a flexible parametric mixture cure model with interval-censored data.
Stat Med. 2016 Mar 30;35(7):1210-25. doi: 10.1002/sim.6767. Epub 2015 Oct 15.
5
Survival trees for interval-censored survival data.
Stat Med. 2017 Dec 30;36(30):4831-4842. doi: 10.1002/sim.7450. Epub 2017 Aug 18.
6
Estimation with interval censored data and covariates.
Lifetime Data Anal. 1997;3(1):77-91. doi: 10.1023/a:1009620319159.
8
Nonparametric kernel estimation of the probability of cure in a mixture cure model when the cure status is partially observed.
Stat Methods Med Res. 2022 Nov;31(11):2164-2188. doi: 10.1177/09622802221115880. Epub 2022 Aug 1.
9
The analysis of multivariate interval-censored survival data.
Stat Med. 2002 Dec 15;21(23):3715-26. doi: 10.1002/sim.1265.
10
On Suitability of Mixture of Generalized Exponential Models in Modeling Right-Censored Medical Datasets Using Conditional Expectations.
Comput Math Methods Med. 2022 Oct 14;2022:7363646. doi: 10.1155/2022/7363646. eCollection 2022.

本文引用的文献

1
2
Coronavirus disease 2019 (COVID-19): survival analysis using deep learning and Cox regression model.
Pattern Anal Appl. 2021;24(3):993-1005. doi: 10.1007/s10044-021-00958-0. Epub 2021 Feb 15.
3
Deep Survival Machines: Fully Parametric Survival Regression and Representation Learning for Censored Data With Competing Risks.
IEEE J Biomed Health Inform. 2021 Aug;25(8):3163-3175. doi: 10.1109/JBHI.2021.3052441. Epub 2021 Aug 5.
4
Network estimation for censored time-to-event data for multiple events based on multivariate survival analysis.
PLoS One. 2020 Oct 1;15(10):e0239760. doi: 10.1371/journal.pone.0239760. eCollection 2020.
5
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
6
Deep learning for survival outcomes.
Stat Med. 2020 Jul 30;39(17):2339-2349. doi: 10.1002/sim.8542. Epub 2020 Apr 13.
7
GAIT: Gene expression Analysis for Interval Time.
Bioinformatics. 2018 Jul 1;34(13):2305-2307. doi: 10.1093/bioinformatics/bty111.
9
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Gastroenterology. 2017 Jun;152(8):1954-1964. doi: 10.1053/j.gastro.2017.02.040. Epub 2017 Mar 7.
10
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验